Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?
- PMID: 24669288
- PMCID: PMC3941783
- DOI: 10.1155/2014/427318
Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?
Abstract
Alzheimer's disease (AD) is the most common form of dementia in the elderly, with increasing prevalence and no disease-modifying treatment available yet. A remarkable amount of data supports the hypothesis that oxidative stress is an early and important pathogenic operator in AD. However, all clinical studies conducted to date did not prove a clear beneficial effect of antioxidant treatment in AD patients. In the current work, we review the current knowledge about oxidative stress in AD pathogeny and we suggest future paths that are worth to be explored in animal models and clinical studies, in order to get a better approach of oxidative imbalance in this inexorable neurodegenerative disease.
References
-
- Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's and Dementia. 2013;9, article e2:63–75. - PubMed
-
- Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiological Reviews. 2001;81(2):741–766. - PubMed
-
- Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Journal of the American Medical Association. 1997;278(16):1349–1356. - PubMed
-
- Wenk GL. Neuropathologic changes in Alzheimer’s disease. Journal of Clinical Psychiatry. 2003;64(supplement 9):7–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
